Searched for
BROWNFIELD PHARMA
Stocks in news: Sun Pharma, Tech Mahindra, Tata Motors, Voltas, ONGCIndian markets saw a dip on Friday, with IT stocks leading the decline. Analysts suggest profit-taking occurred near the 24,150 mark. Despi...- Buy, Sell or Hold: Citi maintains buy on Eicher Motors; Goldman Sachs retains buy on Max HealthcareBrokerages maintain a positive outlook on select large-cap pharmaceutical, automobile, and healthcare stocks, citing strong growth prospect...
- Pharma sector receives Rs 4,975-crore FDI in FY16: GovernmentFDI policy provides for 100 per cent FDI under automatic route in greenfield pharma and upto 100 per cent under government route in brownfi...
- Pharma sector to grow by 20 per cent on relaxed FDI norms: Ananth Kumar"The pharma industry is growing by 14 per cent every year. With relaxed FDI norms, I think pharma sector will grow by 20 per cent," Kumar s...
- FDI green light to spark M&As in pharma sectorUntil now to buy into an Indian enterprise, multinational drug companies needed an approval from FIPB under department of industrial policy...
- FDI up to 74% in brownfield pharma under automatic routeThe government today allowed up to 74 per cent foreign direct investment in the existing pharmaceutical companies through automatic route.
- Government weighs relaxing FDI norms in brownfield pharma companiesAccording to a proposal, FDI up to 49% should be allowed through the automatic route and anything beyond through approval of the FIPB, sour...
- Government to conduct study to assess impact of FDI in pharma industryThe experts would look into the impact of foreign direct investment in the brownfield pharmaceutical companies and access to affordable med...
- Government to commission study on impact of FDI in pharmaceutical companiesThe government is likely to commission a study soon to assess the impact of foreign direct investment in existing pharmaceutical companies
- Department of industrial policy and promotion proposes composite caps for foreign investment"The government’s intention is to harmonise concept of cumulative foreign investment in a company and this will bring more clarity."
- Union Cabinet rejects DIPP proposal to limit FDI in pharmaThe Union Cabinet has rejected a proposal to limit foreign direct investment in domestic manufacturers of “rare and critical” drugs.
- Government not to reduce FDI cap in existing pharma companiesCurrently, 100 per cent FDI is permitted in brownfield pharma firms through clearance from the Foreign Investment Promotion Board (FIPB).
- Cabinet may restrict FDI in pharmaceutical sectorThe proposal of the DIPP, seeks to restrict FDI in brownfield pharma units, an official familiar with the matter said.
- Ban likely on non-compete clause in pharma M&A, may be a ‘deal breaker’Non-compete clauses restrict the promoters of target companies from venturing into the same line of business for a certain numbers of years.
- FIPB clears US pharma major Mylan's Rs 5,168 crore FDI proposalUS-based Mylan Inc's Rs 5,168 crore proposal to acquire Agila Specialties Pvt Ltd -- a subsidiary of pharma firm Strides Arcolab -- was cle...
- Department of Industrial Policy and Promotion may seek FDI ban on critical drug unitsDIPP backed by the health min, may pitch for barring foreign direct investment in existing rare and critical domestic drug making facilitie...
- House panel for complete ban on takeovers of large domestic drugmakers by MNCsThe market share of foreign companies in the list of top 10 pharma companies in India rose from 10.5 per cent in 2004-05 to almost 19 per c...
- Govt to soon finalise FDI policy on pharma sectorChidambaram today said the government will soon finalise the foreign investment policy on brownfield pharmaceutical projects.
- Anand Sharma wants Prime Minister to convene meet to review FDI policy in pharmaCommerce Minister Anand Sharma has urged Prime Minister Manmohan Singh to convene a high-level review meeting to deliberate on the matter.
- DIPP to take call on allowing 49 per cent FDI in pharmaceutical firmsDIPP may consider allowing foreign direct investment of up to 49 per cent through automatic route in existing Indian pharmaceutical firms.
Load More
